Medically trained
Andreina Méndez is a medically trained specialty Dr in Psychiatry (UK) and neuroscientist with international clinical and academic experience in neurodevelopmen al disorders, particularly autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) in adults. She holds a Medical Degree, a Master’s in Autism Spectrum Disorders, and a PhD in Neuroscience.
Her work integrates translational neuroscience with specialist clinical assessment and diagnostic practice, with a focus on lifespan presentations of neurodevelopmental conditions, their comorbidities in adult populations . She has held research positions in leading European institutions such as the Institute of Psychiatry, Psychology and Neurosciences at King’s College London, Imperial College London and Instituto de Investigación Sanitaria at hospital universitario Gregorio Marañon (IISGM), Madrid, Spain and has contributed to peer-reviewed research in neuropsychiatry and autism. Her research portfolio spans multimodal investigations into neural mechanisms implicated in ASD and related disorders, including work on neurotransmitter systems and brain connectivity patterns.
Dr Méndez has also collaborated with the European Brain Council on major policy-oriented initiatives, including theValue of Treatment Study and theAutism and Epilepsy Care Pathway Study, contributing to cross-disciplinary efforts aimed at improving standards of care and health system integration across Europe. Dr. Méndez currently leads a multidisciplinary clinical service team dedicated to adult neurodiversity assessment, therapeutic intervention, and professional education. Beyond academic and clinical domains, Dr. Méndez is active in translating scientific insights into accessible formats for broader audiences. She participates in podcasts, professional dialogues, and public education initiatives to demystify neurodiversity and foster evidence informed perspectives in clinical practice and societal contexts.